Researchers are diligently trying to find new types of treatment for advanced prostate cancer and hormone-refractory prostate cancer (cancer that no longer responds to hormonal therapy). While new treatments are being researched and developed, only a few of these potential new treatments will be approved by the United States Food and Drug Administration (FDA) since some will fail in clinical trials or will be found to have side effects that are too toxic.
As research continues to ideally develop new medications that can cure prostate cancer, new medications are being approved to increase survival times by delaying the progression (spread) of the cancer while helping to maintain or improve the quality of life of patients through therapies with tolerable or minimal side effects.
The most promising research being conducted is in the area of “targeted” medications, which attack or block targets (small proteins or molecules in the body) that are specifically involved in the growth and spread of the tumor or cancer cells. Medications of this type have already been developed to treat other common cancers, such as colon and breast cancer.